⌘K
Loading ticker…
As of 2026-08-24, Microbot Medical, Inc. Common Stock (MBOT) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.0%, relative volume 1.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MBOT is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.4% / -28.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MBOT is held by 2 ETFs as of May 2026. Top owner: AVSC at 0.01% weight, $189K notional.
Held by 5 ETFs · $7M across latest filings · largest weight 0.34% (QQQS).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MBOT Jan avg: 9.07% median: -3.34% win: 50% σ: 38.17% n: 4 2022-04-12 → 2026-07-31 | MBOT Feb avg: 0.27% median: -4.73% win: 25% σ: 24.29% n: 4 2022-04-12 → 2026-07-31 | MBOT Mar avg: -5.89% median: -1.95% win: 25% σ: 14.64% n: 4 2022-04-12 → 2026-07-31 | MBOT Apr avg: -2.07% median: -13.28% win: 20% σ: 37.61% n: 5 2022-04-12 → 2026-07-31 | MBOT May avg: 7.74% median: 2.83% win: 60% σ: 13.49% n: 5 2022-04-12 → 2026-07-31 | MBOT Jun avg: 4.72% median: -0.79% win: 40% σ: 19.80% n: 5 2022-04-12 → 2026-07-31 | MBOT Jul avg: -5.46% median: -2.53% win: 20% σ: 5.71% n: 5 2022-04-12 → 2026-07-31 | MBOT Aug avg: 7.65% median: -4.00% win: 50% σ: 29.18% n: 4 2022-04-12 → 2026-07-31 (current) | MBOT Sep avg: -15.09% median: -12.71% win: 25% σ: 16.87% n: 4 2022-04-12 → 2026-07-31 | MBOT Oct avg: -12.57% median: -15.10% win: 25% σ: 14.11% n: 4 2022-04-12 → 2026-07-31 | MBOT Nov avg: 7.40% median: 6.76% win: 100% σ: 5.16% n: 4 2022-04-12 → 2026-07-31 | MBOT Dec avg: -1.52% median: -1.20% win: 50% σ: 29.28% n: 4 2022-04-12 → 2026-07-31 |